AgingResearch.NewsJoin free

Dubosiella newyorkensis

Dubosiella newyorkensis has been studied in 2 papers since 2023: none in people yet, 2 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 23, 2026: “Gut bacterium reduced artery disease progression in mice”.

Exposure

2 papers study it5 findingsUpdated

1 new paper in 30 daysSee all 2

None of its findings points the other way.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

  • 2 independent labs in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Animals2

What did studies of Dubosiella newyorkensis find?

5

Studies of Dubosiella newyorkensis measured 5 outcomes; the most studied are atherosclerosis progression (1 study), N1-methyl-4-pyridone-3-carboxamide (1) and ACMSD expression (1).

Atherosclerosis progression

downin mice1

1 study

  1. Dubosiella newyorkensis decreases atherosclerosis progression in mice (noise exposure).

    “Supplementation with D. newyorkensis upregulated hepatic ACMSD expression, lowered circulating 4PY levels, and alleviated noise-related atherosclerotic progression in mice.”

    Animalsnoise exposure

    Gut bacterium reduced artery disease progression in mice

    Pharmacological research

N1-methyl-4-pyridone-3-carboxamide

downin mice1

1 study

  1. Dubosiella newyorkensis decreases N1-methyl-4-pyridone-3-carboxamide in mice (noise exposure).

    “Supplementation with D. newyorkensis upregulated hepatic ACMSD expression, lowered circulating 4PY levels, and alleviated noise-related atherosclerotic progression in mice.”

    Animalsnoise exposure

    Gut bacterium reduced artery disease progression in mice

    Pharmacological research

More on N1-methyl-4-pyridone-3-carboxamide

ACMSD expression

upin mice1

1 study

  1. Dubosiella newyorkensis increases ACMSD expression in mice (noise exposure).

    “Supplementation with D. newyorkensis upregulated hepatic ACMSD expression, lowered circulating 4PY levels, and alleviated noise-related atherosclerotic progression in mice.”

    Animalsnoise exposureliver

    Gut bacterium reduced artery disease progression in mice

    Pharmacological research

More on ACMSD expression

Pentosidine

downin mice1

1 study

  1. Dubosiella newyorkensis decreases pentosidine in mice.

    “the reduction of vascular endothelial growth factor (VEGF) and pentosidine (PTD) was better than that of resveratrol in young mice”

    Animals

    Gut microbial characteristical comparison reveals potential anti-aging function of Dubosiella newyorkensis in mice

    Frontiers in endocrinology

More on Pentosidine

Oxidative stress and ROS signaling

downin mice1

1 study

  1. Dubosiella newyorkensis decreases oxidative stress and ROS signaling in mice.

    “The effect of Dubosiella newyorkensis on reducing malondialdehyde (MDA) and increasing superoxide dismutase (SOD) in aged mice were greater than that of resveratrol.”

    Animals

    Gut microbial characteristical comparison reveals potential anti-aging function of Dubosiella newyorkensis in mice

    Frontiers in endocrinology

More on Oxidative stress and ROS signaling

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months
Pharmacological Research

Gut bacterium reduced artery disease progression in mice

In mouse experiments, supplementing a gut bacterium lowered levels of a circulating chemical and reduced the progression of noise-related plaque buildup in arteries.In mouse experiments, supplementing a gut bacterium lowered levels of a circulating chemical and reduced the progression of noise-related plaque buildup in arteries.

Mouse studyGut and microbiome
Paper

Related